Kumar, Sanjeev <br/><br/>
Immunogenicity of recombinant Modified Vaccinia Ankara Viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice.  [electronic resource] 

 -  Viral immunology  2004 
 - 574-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0882-8245 
<br/><br/><label>Standard No.: </label>10.1089/vim.2004.17.574  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--administration & dosage<br/>Amino Acid Sequence<br/>Animals<br/>Disease Models, Animal<br/>Female<br/>Gene Products, gag--chemistry<br/>Genes, env<br/>Genes, gag<br/>Genetic Vectors<br/>HIV Antibodies--blood<br/>HIV Envelope Protein gp120--chemistry<br/>HIV Infections--prevention & control<br/>HIV Protease--genetics<br/>HIV-1--classification<br/>Humans<br/>Interferon-gamma--biosynthesis<br/>Mice<br/>Mice, Inbred BALB C<br/>Molecular Sequence Data<br/>Peptides--chemistry<br/>Recombination, Genetic<br/>Vaccines, Synthetic--administration & dosage<br/>Vaccinia virus--genetics